This robotics startup raised $75 million to automate drug manufacturing. See the pitch deck.
News Source : Business Insider
News Summary
- Multiply Labs raised $75 million in a Series B funding round.
- The company builds robots for manufacturing complex drugs.
- The round was led by NantWorks, a holding company founded by billionaire Patrick Soon-Shiong.
- AstraZeneca is a Multiply customer, and Founders Fund is also an investor in the company.
- "The only way to hit throughput, cost, and quality is with robotics," said CEO Fred Parietti.
- "Someone has to make the drugs," he said.
Multiply Labs CEO Fred PariettiMultiply Labs Multiply Labs raised $75 million to automate drug manufacturing.Its robots make complex drugs like gene therapies and mRNA treatments.
Never miss a story from us, subscribe to our newsletter